Effect of contact avoidance or treatment with oral prednisolone on bronchoalveolar lavage surfactant protein A levels in subjects with farmer's lung

Thorax

Volumn 51, Issue 12, 1996, Pages 1210-1215

  Cormier, Yvon ^a   Israël Assayag, Evelyne ^a   Desmeules, Marc ^a   Lesur, Olivier ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

hypersensitivity pneumonitis; lung immunology; surfactant

Indexed keywords

LUNG SURFACTANT; PREDNISOLONE; PROTEIN A; SURFACTANT ASSOCIATED PROTEIN;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FARMER LUNG; FEMALE; HUMAN; IMMUNOLOGY; LUNG LAVAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029850898     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.12.1210     Document Type: Article

References (27)

1. Gruchow HW, Hoffman RG, Marx JJ, Emanuel DA, Rimm AA. Precipitating antibodies of farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis 1981; 124:411-5.
2. Solal-Celigny PH, Laviolette M, Hébert J, Cormier Y. Immune reactions in the lungs of asymptomatic dairy farmers. Am Rev Respir Dis 1982;126:964-7.
3. Denis M, Bédard M, Gagnon M, Cormier Y, Laviolette M. Involvement of cytokines in the pathogenesis of hypersensitivity pneumonitis; evaluation of immuno-therapeutic measures in a mouse model. Can J Infect Dis 1992;3: 111-4B.
4. Cormier Y, Dakhama A, Israel-Assayag E. Altered immunosuppressive function of alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151:A605.
5. Ansfieid MJ, Kaltreider HB, Benson BJ, Caldwell JL. Immunosuppressive activity of canine pulmonary active surface active material. J Immunol 1979;122:1062-6.
6. Catanzaro A, Richman P, Batcher S, Hallman M. Immunomodulation by pulmonary surfactant. J Lab Clin Med 1988;112:727-34.
7. Juers JA, Rogers RM, McCurdy JB, Cook WW. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. J Clin Invent 1976;58:271-5.
8. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, Van Gold LMG. Pulmonary surfactant protein A enhances the host-defense mechanisms of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990;2:91-8.
9. Hawgood S, Benson BJ, Schilling J, Damm D, Clements JA, White RT. Nucleotide and amino acid sequences between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci USA 1987;84:66-70.
10. Pison U, Shiffer K, Hawgood S, Goerke J. Effects of the surfactant-associated proteins, SP-A, SP-B and SP-C, on phospholipid surface film formation. Prog Respirat Res 1990;25:271-3.
11. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophages. Am J Physiol 1993;264:L338-44.
12. Manz-Keinke H, Plattner H, Schlepper-Schäfer J. Lung surfactant protein A (SP-A) enhances serum independent phagocytosis of bacteria by alveolar macrophages, Eur J Cell Biol 1992;57:95-100.
13. Van Iwaarden JF, Van Strijp JAG, Ebscamp MJM, Welmers AC, Verhoef J, van Golde JMG. Surfactant protein A is an opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am J Physiol 1991;261: L204-9.
14. Guzman J, Wang YM, Kalycioglu O, Schoenfeld B, Hamm H, Bartsh W, et al. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. Acta Cytol 1992;36:668-73.
15. Hamm H, Lührs J, Guzman Y, Rotaeche J, Costabel U, Fabel H, et al. Elevated surfactant protein A in bronchoalveolar lavage farmer's lunguids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994;106: 1766-70.
16. Cormier Y, Schuyler M. Hypersensitivity pneumonitis. In: Bone RC, ed. Textbook of pulmonary medicine. Vol 2, Part M. Interstitial tung disease. St Louis: Mosby-Year Book, 1992:1-9.
17. Cormier Y, Bélanger J, Tardif A, Leblanc P, Laviolette M. Relationship between radiographic changes, pulmonary function, and bronchoalveolar lavage fluid lymphocytes in farmer's lung disease. Thorax 1986;41:28-33.
18. McMahan MJ, Mimouni F Miodovnik M, Hull WM, Whitsett JA. Surfactant-associated protein (SAP-35) in amniotic farmer's lunguid from diabetic and non diabetic pregnancies. Obstet Gynecol 1987;70:94-8.
19. Lesur O, Bernard AM, Bégin RO. Clara cell protein (cc-16) and surfactant-associated protein a (SP-A) in asbestos-exposed workers. Chest 1996;109:467-74.
20. Lesur O, Veldhuizen RAW, Whitsett JA, Hull WM, Possmayer F, Cantin A, et al. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis. Lung 1993;171:63-74.
21. Cotes JE, Hall M. The transfer factor for the lung, normal values in adults. In: Arcangeli P, ed. Normal values for respiratory functions in man. Torino: Pan Minerva Medica, 1970:327-43.
22. Grimby G, Soderholm B. Spirometric studies in normal subjects. III. Static lung volumes and maximum voluntary ventilation in adults with a note on physical fitness. Acta Med Scand 1963;73:199-206.
23. Lesur O, Mancini NM, Janot C, Chabot F, Boitout A, Polu JM, et al. Loss of lymphocyte modulatory control by surfactant lipids extracts from acute hypersensitivity pneumonitis: comparaison with sarcoidosis and idiopathic pulmonary fiibrosis. Eur Respir J 1994;7:1944-9.
24. Cormier Y, Desmeules M. Treatment of hypersensitivity pneumonitis (HP): comparison between contact avoidance and corticosteroids. Can Respir J 1994;1:223-8.
25. Blau H, Riklis S, Kravstov V, Kalina M. Secretion of cytokines by rat alveolar epithelial cells: possible regulatory role of SP-A. Am J Physiol: Lung Cell Mol Physiol 1994; 10:L148-55.
26. Hammar S. In: Rosen PP, Fechner RE, eds. Pathology annual. Part 1, Vol 23. Norwalk: Appleton and Lange, 1988:195-215.
27. Weaver T, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 1991;273:249-64.